AXIM BIOTECHNOLOGIES, INC. Loss Contingency, Receivable, Proceeds
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Loss Contingency, Receivable, Proceeds of $40.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-20.
Discontinued › Notes › Commitment and Contingencies › Loss Contingency
us-gaap:LossContingencyReceivableProceeds · last filed 2023-11-20
- 2023-09-30: Loss Contingency, Receivable, Proceeds 9 month $40.00K.
- 2022-09-30: Loss Contingency, Receivable, Proceeds 9 month $60.06K.
| Period end | Loss Contingency, Receivable, Proceeds 9 month |
|---|---|
| 2023-09-30 | $40.00K 10-Q · filed 2023-11-20 |
| 2022-09-30 | $60.06K 10-Q · filed 2023-11-20 |